NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: a cardiac safety research consortium think tank - Reiffel, J A; Weitz, J I; Reilly, P (Am Heart J, 2016)
, et al; Cardiac Safety Research Consortium presenters and participants.